TP53 and steatosis: Previous studies reported that GSN binds to P53 in HepG2 cells, inhibiting its nuclear translocation and suppressing its activity.[30] In addition, increased hepatic P53 expression has been linked to exacerbated steatosis in the liver, prompting us to focus on P53 in subsequent experiments.